Quarterly report pursuant to Section 13 or 15(d)

SEGMENT REPORTING - Net Sales and Segment Profit (Details)

v3.22.1
SEGMENT REPORTING - Net Sales and Segment Profit (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Segment Reporting Information [Line Items]    
Net sales $ 5,224 $ 3,477
Segment Profit (Loss) 2,038 2,140
Non-cash share-based compensation (500) (1,550)
Depreciation and amortization (517) (579)
Loss from operations (11,893) (7,768)
Loss on debt extinguishment 2,263 0
(Gain) loss on remeasurement of warrant liability (490) 4,851
Foreign exchange loss 345 759
Interest and amortization of debt issuance cost 2,118 978
Other income, net (53) (602)
Loss before loss from equity investment (16,076) (13,754)
Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 5,224 3,477
Segment Profit (Loss) (7,340) (2,252)
Operating Segments | Cannabinoid    
Segment Reporting Information [Line Items]    
Net sales 1,994 677
Segment Profit (Loss) (7,688) (2,864)
Operating Segments | Non-Cannabinoid    
Segment Reporting Information [Line Items]    
Net sales 3,230 2,800
Segment Profit (Loss) 348 612
Other    
Segment Reporting Information [Line Items]    
Unallocated corporate expenses (3,536) (3,387)
Non-cash share-based compensation (500) (1,550)
Depreciation and amortization (517) (579)
Loss from operations $ (11,893) $ (7,768)